Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.
Stewart joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals, where he served in several executive roles, including leading the commercial business unit and the business development function.
He said: “Crescendo is developing very exciting and highly differentiated pipeline of therapeutics.
“I look forward to joining the team and contributing my experience to advance those products, achieve our corporate goals and realise the full potential of the Humabody platform.”
Stewart has over 20 years’ of experience working in the biotechnology field and his expertise lies in growing pre-clinical organisations to commercial enterprises and market launches.
Peter Pack, CEO of Crescendo Biologics, said: “A strong and experienced team is key to reaching our ambitions and Stewart brings broad experience in business and corporate development as well as organisational growth, making him a great addition to our leadership team.”